TY - JOUR
T1 - The importance of human FcγRI in mediating protection to malaria
AU - McIntosh, Richard S.
AU - Shi, Jianguo
AU - Jennings, Richard M.
AU - Chappel, Jonathan C.
AU - De Koning-Ward, Tania F.
AU - Smith, Tim
AU - Green, Judith
AU - Van Egmond, Marjolein
AU - Leusen, Jeanette H.W.
AU - Lazarou, Maria
AU - Van De Winkel, Jan
AU - Jones, Tarran S.
AU - Crabb, Brendan S.
AU - Holder, Anthony A.
AU - Pleass, Richard J.
PY - 2007
Y1 - 2007
N2 - The success of passive immunization suggests that antibody-based therapies will be effective at controlling malaria. We describe the development of fully human antibodies specific for Plasmodium falciparum by antibody repertoire cloning from phage display libraries generated from immune Gambian adults. Although these novel reagents bind with strong affinity to malaria parasites, it remains unclear if in vitro assays are predictive of functional immunity in humans, due to the lack of suitable animal models permissive for P. falciparum. A potentially useful solution described herein allows the antimalarial efficacy of human antibodies to be determined using rodent malaria parasites transgenic for P. falciparum antigens in mice also transgenic for human Fc-receptors. These human IgG1s cured animals of an otherwise lethal malaria infection, and protection was crucially dependent on human FcγRI. This important finding documents the capacity of FcγRI to mediate potent antimalaria immunity and supports the development of FcγRI-directed therapy for human malaria.
AB - The success of passive immunization suggests that antibody-based therapies will be effective at controlling malaria. We describe the development of fully human antibodies specific for Plasmodium falciparum by antibody repertoire cloning from phage display libraries generated from immune Gambian adults. Although these novel reagents bind with strong affinity to malaria parasites, it remains unclear if in vitro assays are predictive of functional immunity in humans, due to the lack of suitable animal models permissive for P. falciparum. A potentially useful solution described herein allows the antimalarial efficacy of human antibodies to be determined using rodent malaria parasites transgenic for P. falciparum antigens in mice also transgenic for human Fc-receptors. These human IgG1s cured animals of an otherwise lethal malaria infection, and protection was crucially dependent on human FcγRI. This important finding documents the capacity of FcγRI to mediate potent antimalaria immunity and supports the development of FcγRI-directed therapy for human malaria.
UR - http://www.scopus.com/inward/record.url?scp=34249703970&partnerID=8YFLogxK
U2 - 10.1371/journal.ppat.0030072
DO - 10.1371/journal.ppat.0030072
M3 - Article
C2 - 17511516
AN - SCOPUS:34249703970
SN - 1553-7366
VL - 3
SP - 647
EP - 658
JO - PLoS Pathogens
JF - PLoS Pathogens
IS - 5
ER -